During the past decade, Regional Hospital Mayen conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Regional Hospital Mayen" are "Lymphoma" (3 trials). Many other conditions were trialed in "Regional Hospital Mayen" in a lesser frequency.

Most popular intervention types in "Regional Hospital Mayen" are "Biological" (3 trials), "Drug" (3 trials), "Radiation" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (3 trials), "doxorubicin hydrochloride" (3 trials), "prednisone" (3 trials), "radiation therapy" (3 trials) and "vincristine sulfate" (3 trials). Other intervention names were less common.

The vast majority of trials in "Regional Hospital Mayen" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Regional Hospital Mayen". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Regional Hospital Mayen, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Regional Hospital Mayen, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".